Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

2',6'-Dihydroxyacetophenone (699-83-2) 's Synthetic route

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 699-83-2

Relevant articles and documents

Microwave-assisted synthesis of derivatives of khellinone under phase-transfer catalytic conditions

Hejchman, Elzbieta  Maciejewska, Dorota  Wolska, Irena

The microwave-assisted synthesis of four new 5-acetyl-4,7-dimethoxy-6- hydroxybenzofuran (khellinone) analogs is described. The structures of the obtained derivatives in the solid state are evaluated on the basis of 13C CP/MAS NMR spectra and theoretical calculations at DFT level. A single crystal X-ray diffraction structure is presented for 8-acetyl-7-hydroxy- 4-methylcoumarin. 1,4-Bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)butane was evaluated for potential anticancer activity in an in vitro screening panel of 60 human tumor cell lines. Selected leukemia, non-small cell lung cancer, CNS, melanoma, ovarian, and breast cancer cell lines were sensitive to this compound.

Antitumor and multikinase inhibition activities of some synthesized coumarin and benzofuran derivatives

Abd Elmageed, Zakaria Y.  Abdelhafez, Omaima M.  Ahmed, Eman Y.  Ahmed, Yasmine H.  Ali, Hamed I.  El-Telbany, Rania Farag A.  Serry, Aya M.  Zaafar, Dalia

Two new series of coumarin and benzofuran derivatives were designed, synthesized, and assessed for their in vitro and in vivo antitumor activities against breast cancer. Compounds 8, 9, 14, 15, and 17 exhibited the best antiproliferative activities (IC50: 0.07?2.94 μM) against the MCF-7 cell line, compared with lapatinib (IC50: 4.69 μM). Compound 14, with the most potent cytotoxic activity against MCF-7 cells, was capable of enhancing preG1 apoptosis and triggering cell cycle arrest at the G2/M phase. The kinase inhibitory activity of compound 14 against a panel of 22 kinases was examined to reveal multikinase inhibition within ?39% to ?97%. Furthermore, compound 14 exhibited potent in vivo Ehrlich (mammary adenocarcinoma) tumor regression, positive caspase-3, and negative EGFR immunoreaction, and was capable of elevating the catalase level. The physicochemical properties and pharmacokinetic parameters of compound 14 were investigated in silico for its druglikeness.

Related Suppliers

Switzerland | Contact:sir
Tel:41 22 990 12 01
Inquiry
Italy | Contact:sir
Tel:+39.039.6918181/6918117
Inquiry
India | Contact:Sridhara Mishra
Tel:+91-8008155547
Inquiry
India | Contact:sir
Tel:+ 91-11-49404040
Inquiry
India | Contact:G.V.Narendra Raju
Tel:+91-9246833182
Inquiry
India | Contact:Namrata Kanhere
Tel:+91-22-40068689/ 40148689
Inquiry
Austria | Contact:sir
Tel:+43 1 545 69 85 48
Inquiry
United States | Contact:sir
Tel:(858)348-7819
Inquiry
United States | Contact:sir
Tel:1-302-737-5005
Inquiry
United States | Contact:Steve Johnson
Tel:-00
Inquiry
  • ©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
  • [Hangzhou]86-0571-87562588,87562578,87562573 Our Legal adviser: Lawyer